Publications

Medical image analysis

Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge.

01-01-2027

Annals of oncology : official journal of the European Society for Medical Oncology

Neoadjuvant nivolumab plus gemcitabine-cisplatin followed by postsurgical adjuvant nivolumab versus neoadjuvant gemcitabine-cisplatin in patients with muscle-invasive bladder cancer: final results from the phase III CA017-078 trial.

31-12-2026

Drug delivery

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

31-12-2026

ESMO real world data and digital oncology

From registration to insight: how STRONG AYA transforms registry data to enhance decision-support tools for adolescent and young adult oncology.

01-12-2026

Advances in radiation oncology

Evaluation of Cardiac Function After Stereotactic Body Radiation Therapy for Lung Tumors: Results of the Prospective Explorative Heart-Lung Study.

01-12-2026

mAbs

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate.

01-12-2026

International journal of cancer

Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.

15-11-2026

British journal of cancer

Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

01-11-2026

The Lancet. Oncology

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer.

01-11-2026

Lancet (London, England)

Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

31-10-2026

Endocrine

Score interpretation thresholds for the European Organisation for Research and Treatment of Cancer thyroid cancer quality of life questionnaire (EORTC QLQ-THY34). An international prospective study.

29-10-2026

Nature cell biology

Tubulin acetylation regulates nuclear shape fluctuations and DNA repair.

28-10-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Final prespecified analysis of the phase 3 LITESPARK-011 study: belzutifan plus lenvatinib versus cabozantinib for advanced renal cell carcinoma after anti-PD-(L)1 therapy.

25-10-2026

International journal of computer assisted radiology and surgery

Camera calibration and tracking for augmented reality during robotic surgery.

25-10-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.

24-10-2026

Annals of surgical oncology

Predictors of Immediate Therapeutic Lymph Node Dissection Instead of Index Lymph Node After Neoadjuvant Checkpoint Inhibitors: Lessons Learned from the PRADO Trial.

24-10-2026

Journal of cancer survivorship : research and practice

Assessing physical activity using Fitbit trackers and the association with quality of life among newly diagnosed patients with hematologic cancer.

23-10-2026

World journal of urology

Clinical response outweighs baseline nodal stage in treatment selection and survival of clinically node-positive bladder cancer.

23-10-2026

Journal of medical Internet research

Ethics of Telerehabilitation in Supportive Cancer Care Through a Responsible Innovation Lens.

22-10-2026

Oral oncology

Consensus on current clinical workflow and future use of 3D models in parotid gland tumor surgery: A Delphi study.

22-10-2026

Cell reports. Medicine

A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics.

20-10-2026

Frontiers in immunology

Platform-based manufacturing of tumor-infiltrating lymphocytes derived from different solid tumor types.

20-10-2026

Oral oncology

Distinct epigenetic signatures define HPV-positive and HPV-negative tonsil carcinomas.

17-10-2026

iScience

Cancer cell-intrinsic rewiring of the colorectal cancer secretome.

16-10-2026

European journal of cancer (Oxford, England : 1990)

70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.

16-10-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

Brigimadlin versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety, and Translational Data from Brightline-1, a Randomized Phase II/III Trial.

15-10-2026

npj digital surgery

Artificial intelligence-assisted spatial correction of augmented reality projections; implementing radiation mapping during radioguided robotic surgery.

15-10-2026

Science (New York, N.Y.)

Frequency encoding regulates cell type composition in the small intestine.

15-10-2026

European journal of cancer (Oxford, England : 1990)

A health-related quality of life measurement strategy for solid rare cancers: Primary findings from the EORTC Quality of Life Group (QLG) QoL Rare Cancer Study.

14-10-2026

Cell host & microbe

Protein landscape of the chromatin domains in the malaria parasite Plasmodium falciparum.

14-10-2026

Immunity

Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction.

13-10-2026

Insights into imaging

Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial.

13-10-2026

Journal of the National Cancer Institute

Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancer.

13-10-2026

Stem cell reports

Methylome profiling of SetDB1-deficient ESCs reveals coordinated epigenetic cross-talk during pluripotency.

13-10-2026

BJU international

[¹⁸F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract urothelial carcinoma.

13-10-2026

International journal of cancer

Persistent Health Disparities Among Adult Cancer Survivors.

09-10-2026

Journal of cancer policy

Perspectives in the value assessment of comprehensive genomic profiling: A multi-criteria decision analysis in NSCLC among stakeholders.

09-10-2026

Nature reviews. Cancer

Mapping the functional dark proteome in cancer.

08-10-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.

08-10-2026

Proceedings of the National Academy of Sciences of the United States of America

The PKMYT1-ALDOA axis drives chemoresistance in cholangiocarcinoma by enhancing glycolysis and MRE11 lactylation.

06-10-2026

Cell metabolism

Diet-microbiome interactions enhance cancer immunotherapy in obesity.

06-10-2026

Advanced materials (Deerfield Beach, Fla.)

Charge-Reversed Lipid Nanoparticles Enable Encapsulation of Pt₂L₄ Nanocages for In vivo Anti-Cancer Treatment.

06-10-2026

Nature cell biology

Global and specific mechanisms stimulate mistranslation in cancer.

05-10-2026

Lancet (London, England)

Distinguishing AYA oncology from early-onset cancer.

03-10-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Digital symptom monitoring in cancer care: an exploratory evaluation of low uptake and engagement.

02-10-2026

European journal of nuclear medicine and molecular imaging

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

01-10-2026

European journal of nuclear medicine and molecular imaging

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

01-10-2026

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.

01-10-2026

Nature biotechnology

A single-chain derivative of an integrin-activating antibody potentiates organoid growth in Matrigel and collagen hydrogels.

01-10-2026

Molecular cell

An unexpected role for cyclin E-CDK2 in regulating responses to cancer immunotherapy.

01-10-2026

Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge.

Neoadjuvant nivolumab plus gemcitabine-cisplatin followed by postsurgical adjuvant nivolumab versus neoadjuvant gemcitabine-cisplatin in patients with muscle-invasive bladder cancer: final results from the phase III CA017-078 trial.

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

From registration to insight: how STRONG AYA transforms registry data to enhance decision-support tools for adolescent and young adult oncology.

Evaluation of Cardiac Function After Stereotactic Body Radiation Therapy for Lung Tumors: Results of the Prospective Explorative Heart-Lung Study.

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate.

Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.

Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer.

Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

Score interpretation thresholds for the European Organisation for Research and Treatment of Cancer thyroid cancer quality of life questionnaire (EORTC QLQ-THY34). An international prospective study.

Tubulin acetylation regulates nuclear shape fluctuations and DNA repair.

Final prespecified analysis of the phase 3 LITESPARK-011 study: belzutifan plus lenvatinib versus cabozantinib for advanced renal cell carcinoma after anti-PD-(L)1 therapy.

Camera calibration and tracking for augmented reality during robotic surgery.

Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.

Predictors of Immediate Therapeutic Lymph Node Dissection Instead of Index Lymph Node After Neoadjuvant Checkpoint Inhibitors: Lessons Learned from the PRADO Trial.

Assessing physical activity using Fitbit trackers and the association with quality of life among newly diagnosed patients with hematologic cancer.

Clinical response outweighs baseline nodal stage in treatment selection and survival of clinically node-positive bladder cancer.

Ethics of Telerehabilitation in Supportive Cancer Care Through a Responsible Innovation Lens.

Consensus on current clinical workflow and future use of 3D models in parotid gland tumor surgery: A Delphi study.

A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics.

Platform-based manufacturing of tumor-infiltrating lymphocytes derived from different solid tumor types.

Distinct epigenetic signatures define HPV-positive and HPV-negative tonsil carcinomas.

Cancer cell-intrinsic rewiring of the colorectal cancer secretome.

70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.

Brigimadlin versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety, and Translational Data from Brightline-1, a Randomized Phase II/III Trial.

Artificial intelligence-assisted spatial correction of augmented reality projections; implementing radiation mapping during radioguided robotic surgery.

Frequency encoding regulates cell type composition in the small intestine.

A health-related quality of life measurement strategy for solid rare cancers: Primary findings from the EORTC Quality of Life Group (QLG) QoL Rare Cancer Study.

Protein landscape of the chromatin domains in the malaria parasite Plasmodium falciparum.

Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction.

Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial.

Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancer.

Methylome profiling of SetDB1-deficient ESCs reveals coordinated epigenetic cross-talk during pluripotency.

[18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract urothelial carcinoma.

Persistent Health Disparities Among Adult Cancer Survivors.

Perspectives in the value assessment of comprehensive genomic profiling: A multi-criteria decision analysis in NSCLC among stakeholders.

Mapping the functional dark proteome in cancer.

RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.

The PKMYT1-ALDOA axis drives chemoresistance in cholangiocarcinoma by enhancing glycolysis and MRE11 lactylation.

Diet-microbiome interactions enhance cancer immunotherapy in obesity.

Charge-Reversed Lipid Nanoparticles Enable Encapsulation of Pt2L4 Nanocages for In vivo Anti-Cancer Treatment.

Global and specific mechanisms stimulate mistranslation in cancer.

Distinguishing AYA oncology from early-onset cancer.

Digital symptom monitoring in cancer care: an exploratory evaluation of low uptake and engagement.

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

Development and validation of an LC-MS/MS method for the quantification of the KRASG12C inhibitor divarasib.

A single-chain derivative of an integrin-activating antibody potentiates organoid growth in Matrigel and collagen hydrogels.

An unexpected role for cyclin E-CDK2 in regulating responses to cancer immunotherapy.

This site uses cookies

[¹⁸F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract urothelial carcinoma.

Charge-Reversed Lipid Nanoparticles Enable Encapsulation of Pt₂L₄ Nanocages for In vivo Anti-Cancer Treatment.

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.